John Lombard

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Universität Ulm(Current)

Technical University of Munich

Merck & Co., Inc., Rahway, NJ, USA (United States)

John Lombard is an author at Universität Ulm specializing in neuromuscular blocking agents, double-blind trials, and neuromuscular blocking agent administration.

ORCID

Publications per year

2021–2021

Publications

Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial

Jay Horrow, Wen Li, Manfred Blobner et al. · BMC Anesthesiology · 2021 · 32 citations · Full text

Medicine, Perioperative Medicine, Pharmacotherapy +17

A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants

W. Joseph Herring, Yuki Mukai, Aobo Wang et al. · BMC Anesthesiology · 2021 · 14 citations · Full text

Medicine, Perioperative Medicine, Surgery +14

1–2 of 2